Clinical Trial Update: Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian Infants [Phase 3]

View source ↗

Summary

Phase 3 trial comparing DTaP-IPV-Hep B-PRP~T Combined Vaccine with Infanrix Hexa in healthy Peruvian infants; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Infection
• Hepatitis B
• Pertussis
• Tetanus

Drugs mentioned

• DTaP-IPV-Hep B-PRP~T Combined Vaccine
• Infanrix Hexa (DTPa-HBV-IPV/Hib)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Diphtheria, Tetanus | Phase 3 | Status: COMPLETED | Results posted: 2014-04-02